Charlotte's Web Holdings, Inc. (CWBHF) generates frequent news as a botanical wellness innovation company and market leader in hemp extract wellness and hemp-derived CBD wellness products. Headquartered in Louisville, Colorado and listed on the Toronto Stock Exchange under the symbol CWEB, the company issues regular updates on product launches, operational developments, financial results, and regulatory engagement.
News about Charlotte's Web often highlights new product introductions across CBD oil tinctures, CBD gummies, CBN and CBG gummies, hemp-derived THC microdose gummies, Brightside hemp-derived THC gummies, functional mushroom gummies, and CBD pet products for dogs. Recent announcements include the launch of Quiet Sleep Mushroom Gummies, a melatonin-free and cannabinoid-free sleep support product, and Knockout hemp THC sleep gummies under the Brightside brand, which use a rapid-onset delivery technology.
Investors and followers can also expect coverage of the company's financial performance through quarterly earnings releases, where Charlotte's Web discusses revenue trends, cost structure initiatives, and manufacturing internalization, particularly for gummy production. Additional news items describe the formation of a Scientific Advisory Board, expansion of the medical channel strategy, and participation in a Medicare and Medicaid Innovation pilot program to provide CBD options for senior oncology patients.
Regulatory and policy developments are another recurring theme. Charlotte's Web reports on federal and state-level hemp and CBD regulation, its involvement in industry coalitions such as ONE HEMP, and its perspective on proposed THC limits for hemp-derived products. Updates related to DeFloria, Inc., the Phase 2 clinical-stage botanical pharmaceutical company formed with AJNA BioSciences PBC and supported by a subsidiary of British American Tobacco plc, also appear in the news, including progress on AJA001 oral solution for irritability associated with autism spectrum disorder.
For investors, analysts, and consumers, the Charlotte's Web news feed provides ongoing insight into the company's product pipeline, strategic priorities, regulatory environment, and role in the evolving hemp and botanical wellness market.
Charlotte's Web has expanded its gummy product line by introducing three new offerings: Daily Wellness, THC-Free, and Immunity gummies. These products will be available online and shipped to over 14,000 retail partners across the U.S. starting next month. The new gummies feature full-spectrum and broad-spectrum hemp extracts with varying CBD strengths and added vitamins for enhanced wellness. The CEO emphasized the importance of gummies as a leading delivery format in the rapid-growing hemp wellness sector. All products are vegan and non-GMO.
Charlotte's Web Holdings reported Q2 2021 financial results, showing a 11.4% year-over-year revenue growth to $24.2 million. Direct-to-consumer (DTC) revenue increased slightly by 1.0%, while business-to-business (B2B) revenue surged by 37.7%. Gross profit rose to 65.5% of revenue. The company reduced operating expenses by 15.2% and improved adjusted EBITDA losses to ($3.9 million). With $27.1 million in cash and $90.1 million in working capital, Charlotte's Web is positioned for growth in retail and the cannabis wellness market.
Charlotte's Web Holdings announced a collaborative research project with Colorado State University focusing on the phytochemical profile of hemp extracts. This first phase explores how genetic factors, environmental conditions, and extraction methods influence cannabinoid profiles in full-spectrum hemp extracts. Under the guidance of Dr. Jessica Prenni, the research aims to standardize chemical profiles for consistency. The project is part of Charlotte's Web's commitment to advancing scientific understanding of hemp, with phase I findings expected to be published after peer review.
Charlotte's Web has announced a multi-year exclusive agreement with Life Time, allowing its hemp CBD products to be sold at over 140 Life Time Athletic Clubs and during events across the U.S.
This partnership includes in-club signage and features in Experience Life magazine. Products will be available online at shop.lifetime.life. CEO Deanie Elsner emphasized the strategic fit with Life Time’s wellness mission, while Life Time’s Kimo Seymour noted Charlotte's Web's strong reputation in the CBD sector.
Charlotte's Web Holdings Inc. has appointed Tim Saunders to its Board of Directors, enhancing its governance and financial oversight. Saunders, former CFO of Canopy Growth, brings extensive experience, having managed over C$6.4 billion in financings and 31 acquisitions. He is expected to strengthen the company's expansion efforts into Canada, Israel, Europe, and the U.K. His broad insight into global markets will assist in navigating regulatory challenges as the company seeks growth in hemp and cannabis sectors.
Charlotte's Web Holdings, Inc. (CWBHF) announced the appointment of Wessel Booysen as Chief Financial Officer (CFO) on June 15, 2021. Booysen, a former executive at Molson Coors, brings over a decade of experience in finance and international expansion, helping to drive the company’s growth plans. He has a proven track record in the Asia Pacific and Africa regions, where he achieved double-digit growth. Outgoing CFO Russ Hammer will assist in a transition period before his retirement in August 2021.
Charlotte's Web Holdings (CWBHF) announced a collaboration with the University of Colorado-Boulder's REACH Center for a preclinical study on the effects of CBD and CBN on anxiety and sleep. This research aims to provide scientific validation for the benefits of full-spectrum hemp formulations, addressing the limited data on cannabinoids other than CBD and THC. The study is expected to enhance understanding of how specific ratios of cannabinoids can improve sleep quality and is backed by significant research funding.
Charlotte's Web Holdings (CWBHF) reported a 9.1% increase in Q1 2021 revenue, totaling $23.4 million, driven by a 14.5% rise in DTC eCommerce sales. Gross profit decreased to 58.4% of revenue, reflecting a shift in product mix. B2B sales declined by 1.4%, but retail sales showed a 11% increase when excluding certain services. The company holds $35 million in cash and has expanded its market share. Adjusted EBITDA loss narrowed to $4.7 million, but operating expenses rose 2.9%. A forward-looking purchase agreement for the Stanley Brothers cannabis business was secured pending legalization.
On May 5, 2021, Charlotte's Web (CWBHF) announced a partnership with U.S. soccer star Carli Lloyd. Following her knee surgery, Lloyd turned to CBDMEDIC products for pain relief, becoming an advocate for hemp-derived CBD's benefits for athletes. The partnership highlights Lloyd's personal recovery story, including products like Active Sport Pain Relief Ointment and Arthritis Aches and Pain Relief Cream. This announcement comes just before the Summer Games, where CBD is no longer banned, potentially boosting the brand's visibility among athletes.
Charlotte's Web Holdings announced the approval of three of its proprietary hemp cultivars for outdoor cultivation in Canada by Health Canada. This marks a significant step for the company as its CW1AS1 variety, among others, will enable the cultivation of CBD products within Canada's shorter growing season. Currently, CBD products from the U.S. face import restrictions into Canada. The approved cultivars aim to address the underdeveloped hemp CBD market in Canada, potentially opening access to Charlotte's Web products and expanding its growth opportunities.